Related Articles
Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration
MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and <em>in vitro</em> experiments
Feasibility of primary human cell cultures as a model for adamantinomatous craniopharyngioma research: Evidence from RNA‑Seq analysis
Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas
S100A8/A9 is associated with estrogen receptor loss in breast cancer